Article
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
2026-04-18
Abstract excerpt
PIGA-CDG is a congenital disorder of glycosylation caused by pathogenic partial loss-of-function variants in the PIGA gene. PIGA encodes an enzyme responsible for the catalytic transfer of N-acetylglucosamine to phosphatidylinositol during the first step of glycosylphosphatidylinositol anchor biosynthesis. Loss of this enzyme has a widespread phenotypic impact, but primarily results in neurological symptoms includ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13b27c10-81f7-5822-9db6-4164a9665a9b
- DOI
- 10.64898/2026.04.17.719256
